PROGNOSTIC VALUE OF 18F-FDG POSITRON EMISSION TOMOGRAPHY IN THE EARLY EVALUATION OF THE EFFICIENCY OF TREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMAS

QR Code

PROGNOSTIC VALUE OF 18F-FDG POSITRON EMISSION TOMOGRAPHY IN THE EARLY EVALUATION OF THE EFFICIENCY OF TREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMAS

Objective: to define the role of 18F-FDG positron emission tomography (PЕT) performed after 2–3 chemotherapy cycles in the prediction of disease prognosis and to identify a group of patients requiring more intensive treatment.Material and methods. Seventy-one patients with nonHodgkin lymphoma of dif...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. M. Khodzhibekova, L. A. Tyutin, N. A. Kostenikov, N. V. Il’in, Yu. N. Vinogradova
Format:	Article
Language:	English
Published:	Luchevaya Diagnostika, LLC 2016-02-01
Series:	Вестник рентгенологии и радиологии
Subjects:	18f-fdg positron emission tomography non-hodgkin lymphoma chemotherapy
Online Access:	https://www.russianradiology.ru/jour/article/view/40
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

18F-FDG positron emission tomography in the diagnosis and staging of marginal zone non-Hodgkin lymphomas
by: M. M. Khodzhibekova, et al.
Published: (2016-02-01)

Predictive value of initial involvement and early response assessment using positron‑emission tomography with 18F‑FLT in patients with non‑Hodgkin lymphoma
by: Yu. N. Likar, et al.
Published: (2014-07-01)

Determination of Hodgkin and non-Hodgkin lymphoma stage with combined positron-emission and computed tomography
by: I. V. Boikov, et al.
Published: (2011-12-01)

Dosimetric evaluation of extremities in 18F-FDG PET/CT procedure using Monte Carlo Geant4 code
by: Paula Rocha Pessanha, et al.
Published: (2019-10-01)

POSITRON EMISION TOMOGRAPHY FOR DETECTION OF DISTANT METASTASES IN PATIENTS WITH BREAST CANCER
by: N. G. Chanchikova, et al.
Published: (2020-03-01)

[18F]FDG/PET: a non-invasive technique for the study of stroke in murine and rat models
by: B. G. A. Schirmer, et al.
Published: (2023-04-01)

The role of <sup>18</sup>F-FDG PET/CT in evaluation of therapy effectiveness and prognosis of lymphomas
by: N. G. Chanchikova, et al.
Published: (2021-07-01)

Estimation of dose distribution in occupationally exposed individuals to FDG-18F
by: Isabelle Viviane Batista de Lacerda, et al.
Published: (2015-05-01)

18F-FDG PET and combined diffusion weighted MRI features in pleural infection: A case report
by: KyungAh Chun, MD, PhD
Published: (2025-09-01)

Complex Immunotherapy-mediated Response Patterns Depicted on Serial 18F-FDG PET imaging of Hodgkin Lymphoma Patient Undergoing Pembrolizumab Therapy
by: Mohanad Badarneh, et al.
Published: (2025-07-01)

Comparing the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in breast cancer recurrence: a systematic review and meta-analysis
by: Shiqing Liu, et al.
Published: (2025-08-01)

Comparison of 18F-FDG and 68-PSMA-11 in PET for prostate cancer diagnosis
by: Natalia Fulle, et al.
Published: (2022-12-01)

Patient dose reduction by changing the amount of 18F-FDG radiopharmaceutical injected
by: Fernanda Guerra Paiva, et al.
Published: (2019-02-01)

Whole-Body Diffusion-Weighted Magnetic Resonance Imaging and Positron Emission Tomography Combined with Computed Tomography in the Staging of Lymphomas
by: S. A. Kharuzhyk, et al.
Published: (2020-01-01)

Primary Mediastinal B-Cell Lymphoma and [18F]FDG PET/CT: What We Learned and What Is New
by: Anna Giulia Nappi, et al.
Published: (2025-04-01)

<sup>18</sup>F-FDG PET/CT in the Diagnosis of Cervical Cancer
by: A. V. Leontyev, et al.
Published: (2022-12-01)

18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IN CANCER PATIENTS: A WHOLE-BODY EXAMINATION PROCEDURE
by: O. V. Mukhortova, et al.
Published: (2014-09-01)

DETECTION OF EXTRANODAL INVOLVEMENT IN PATIENTS WITH LYMPHOMAS USING THE COMBINED PET-CT
by: А. V. Vazhenin, et al.
Published: (2016-02-01)

The Role of [18F]FDG PET Imaging for the Assessment of Pulmonary Lymphangitic Carcinomatosis: A Comprehensive Narrative Literature Review
by: Francesco Dondi, et al.
Published: (2025-06-01)

Prognostic Value of Multiple Manual Segmentation Methods for Diffuse Large B-Cell Lymphoma with <sup>18</sup>F-FDG PET/CT
by: Andrej Doma, et al.
Published: (2025-06-01)

The utility of quantitative 18F-FDG PET/CT-derived parameters as prognostic factors for predicting overall survival in radioiodine-refractory differentiated thyroid cancer
by: Mai Son, et al.
Published: (2025-07-01)

Assessment of Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Carcinoma of Unknown Primary
by: S. A. Yaremenko, et al.
Published: (2021-09-01)

PROGNOSTIC SIGNIFICANCE OF POSITRON EMISSION TOMOGRAPHY IN AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NON-HODGKIN’S LYMPHOMA
by: V. G. Potapenko, et al.
Published: (2017-01-01)

Monitoring internal contamination from OEW of an 18F-FDG production plant: WBC or head counting setup?
by: Bruno Melo Mendes, et al.
Published: (2019-07-01)

A case of invasive lobular carcinoma, highlighting the emerging role of 18F-Fluoroestradiol PET
by: Michael Wallace, MMS, MS, et al.
Published: (2025-10-01)

Atypical Uptake of 18<sup>F</sup>DG in White Adipose Tissue During PET/CT in Children
by: M. M. Dunaikin, et al.
Published: (2023-08-01)

<sup>18</sup>F-fluoroethyltyrozine positron emission tomography combined with computed tomography and computed tomography perfusion in complex diagnostic of glial brain tumors
by: A. I. Pronin, et al.
Published: (2020-02-01)

Value of accelerated hyperfraction dozes of radiation in primary radiation treatment for Hodgkin’s lymphoma
by: N. V. Ilyin, et al.
Published: (2022-11-01)

Possibilities of positron emission tomography in the diagnosis of primary and recurrent ovarian cancer: a review of literature
by: L. A. Ashrafyan, et al.
Published: (2014-07-01)

Diffusion-weighted magnetic resonance imaging as an alternative to positron emission tomography combined with computed tomography with <sup>18</sup>F-fluorodeoxyglucose in patients with lymphomas: a literature review and clinical observations
by: S. A. Alekseev, et al.
Published: (2025-03-01)

The research on the association between genetic alterations of DLBCLs and 18F-FDG PET/CT SUVmax and their clinical significance
by: TIAN Tian, CHEN Chen, WEI Ran, BAO Longlong, GU Bingxin, ZHANG Qunling, CAO Junning, YU Baohua, LI Xiaoqiu, ZHOU Xiaoyan
Published: (2025-06-01)

Hodgkin lymphoma: current conception and unresolved questions
by: Gurtovoj V.A., et al.
Published: (2010-01-01)

COMPLEX ESTIMATION OF BRONCHOPULMONARY SYSTEM IN PATIENTS WITH HODGKINS LYMPHOMA
by: Yu. N. Obgolts, et al.
Published: (2012-02-01)

ORBITAL NON-HODGKIN’S LYMPHOMAS
by: S. V. Saakyan, et al.
Published: (2015-04-01)

The application of PET/CT with 18F-FDG in the differential diagnosis of lung solitary lesions
by: G. V. Afonin, et al.
Published: (2022-09-01)

Diagnostic Utility of <sup>18</sup>F-FDG PET/CT in Infective Endocarditis
by: Corina-Ioana Anton, et al.
Published: (2025-06-01)

Comparison of [18F]AlF-NOTA-FAPI-04 PET/CT and [18F]FDG PET/CT for diagnosing lymph node metastasis in malignant tumors
by: Wanjing Zhou, et al.
Published: (2025-07-01)

Prognostic value of a simple distance index derived from PET maximum intensity projection
by: Isaac Kargar Samani, et al.
Published: (2025-07-01)

New approaches for combined therapy of Hodgkin's lymphoma
by: P. V. Dacenko, et al.
Published: (2022-11-01)

Health of children born to women after radiation and chemotherapy for Hodgkin's lymphoma
by: A. A. Danilenko, et al.
Published: (2014-09-01)